Unit 15, 4th Floor, No. 47, South Khordmand St., Tehran, Iran. |
+98 21 88309291, 88825946, 88311666
Actobiochem, a leading player in Iran’s pharmaceutical industry, organized a specialized panel on “Pharmaceutical and Medical Bioterrorism” in collaboration with health sector professionals during the Iran Health International Exhibition 2023.
The event, held on May 20, 2023, aimed to address the threats posed by bioterrorism in the pharmaceutical and medical sectors and to explore the role of advanced technologies in preventing such threats. During the panel, Dr. Pirouram, CEO of Actobiochem, emphasized the significance of this issue, stating:
"Pharmaceutical bioterrorism is a serious challenge that can endanger public health. At Actobiochem, we leverage advanced technologies and foster scientific collaborations to ensure the security of the pharmaceutical supply chain and counter these threats."
The panel featured representatives from relevant organizations and senior executives from the pharmaceutical industry, focusing on discussions about security challenges in the supply chain and the critical role of high-quality Active Pharmaceutical Ingredients (API) in combating such threats.
As one of the key programs of the Iran Health Exhibition, the Pharmaceutical and Medical Bioterrorism Panel provided a valuable opportunity to examine various aspects of this challenge and strengthen cooperation between scientific and industrial entities. The panel received significant attention from professionals in the health and pharmaceutical sectors.
Actobiochem, a distinguished subsidiary of Actover Holding, not only participated in the International Pharmex Exhibition but also proudly received a prestigious award for its outstanding contributions to the pharmaceutical industry. This recognition highlights the company’s innovative advancements in the production of Active Pharmaceutical Ingredients (API) and its commitment to excellence. The award acknowledges Actobiochem’s achievements […]
Actobiochem, a prominent subsidiary of Actover Holding, proudly participated in the International Pharmex Exhibition, one of the most significant global events in the pharmaceutical industry. This exhibition provided a unique platform to showcase advancements and innovations in Active Pharmaceutical Ingredient (API) production. Actobiochem presented its diverse range of products in key therapeutic areas such as […]
Actobiochem, a subsidiary of Actover Holding, was established to produce Active Pharmaceutical Ingredients (API) and has succeeded in driving advancements in Iran’s pharmaceutical industry.
All rights reserved by Actobiochem Pharmaceutical Compony.
Leave a Reply